The John Sedor lab studies the molecular and genetic bases of kidney disease to develop new therapies and diagnostics.
Coming soon.
Fellowship - University Hospitals of Cleveland Health System
Nephrology
Cleveland, OH USA
1984
Residency - University Hospitals of Cleveland Health System
Internal Medicine
Cleveland, OH USA
1981
Medical Education - University of Virginia
Charlottesville, VA USA
1978
Undergraduate - University of Virginia
Charlottesville, VA USA
1974
Inflammation and fibrosis - Signaling and metabolic networks
View publications for John Sedor, MD
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Jayapandian, C.P., Y. Chen, A.R. Janowczyk, M. B. Palmer, C.A. Cassol, M. Sekulic, J.B. Hodgin, S.M. Hewitt, J. O’Toole, P Toro, J.R. Sedor, Barisoni, and A. Madabhushi. Development and evaluation of deep learning-based segmentation of histologic structures in the kidney cortex with multiple stains. Kidney Int. 2020 Aug 21.
Crawford, D.C., J. Lin, J.N. Cooke Bailey, T. Kinzy, J.R. Sedor, J.F. O’Toole, and W.S. Bush. Frequency of ClinVar pathogenic variants in chronic kidney disease patients surveyed for return of research results at a Cleveland public hospital. Pac. Symp. Biocomp. 25: 575-586, 2020.
Bruggeman, L.A., Z. Wu, L.Luo, S. Madhavan, P.E. Drawz, D.B. Thomas, L. Barisoni, J.F. O’Toole,and J.R. Sedor. PLoS One. 2019 Oct 29; 14: e0224408.
Madhavan, S.M., J.F. O’Toole, M. Konieczkowski, L. Barisoni, D.B. Thomas, S. Ganesan, L.A. Bruggeman, M. Buck, and J.R. Sedor. APOL1 Variants Change C-terminal Conformational Dynamics and binding to SNARE protein VAMP8. JCI Insight, 2017 Jul 20;2(14). pii: 92581. doi: 10.1172/jci.insight.92581.
Our education and training programs offer hands-on experience at one of the nationʼs top hospitals. Travel, publish in high impact journals and collaborate with investigators to solve real-world biomedical research questions.
Learn MoreDrs. Sedor and Boron are leading a collaboration of Cleveland biomedical institutions to address gaps in community health and training
Drs. Bruggeman, Sedor and O’Toole will investigate the pathogenic mechanisms of chronic kidney disease to develop greater understanding of genetic susceptibility and develop new treatment strategies.
Dr. Bruggeman shows in a new study that genetic variants to the APOL1 gene are associated with increased risk for pregnancy-induced hypertension in African American women.
By studying a model of HIV-associated nephropathy, a group of kidney disease researchers and clinicians discovered that in patients with the APOL1 risk gene, the presence of an environmental stressor, like a virus, can trigger cell changes that lead to chronic kidney diseases.